Cargando…

Lack of antiviral activity of darunavir against SARS-CoV-2

OBJECTIVES: Given the high need and the absence of specific antivirals for treatment of COVID-19 (the disease caused by severe acute respiratory syndrome-associated coronavirus-2 [SARS-CoV-2]), human immunodeficiency virus (HIV) protease inhibitors are being considered as therapeutic alternatives. M...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Meyer, Sandra, Bojkova, Denisa, Cinatl, Jindrich, Van Damme, Ellen, Buyck, Christophe, Van Loock, Marnix, Woodfall, Brian, Ciesek, Sandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7258847/ https://www.ncbi.nlm.nih.gov/pubmed/32479865 http://dx.doi.org/10.1016/j.ijid.2020.05.085

Ejemplares similares

In vitro activity of itraconazole against SARS‐CoV‐2
por: Van Damme, Ellen, et al.
Publicado: (2021)

Development and optimization of a high‐throughput screening assay for in vitro anti‐SARS‐CoV‐2 activity: Evaluation of 5676 Phase 1 Passed Structures
por: Chiu, Winston, et al.
Publicado: (2022)

Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants
por: Bojkova, Denisa, et al.
Publicado: (2022)

Growth Factor Receptor Signaling Inhibition Prevents SARS-CoV-2 Replication
por: Klann, Kevin, et al.
Publicado: (2020)

SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
por: Bojkova, Denisa, et al.
Publicado: (2022)

Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings
por: Widera, Marek, et al.
Publicado: (2021)

Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant of SARS-CoV-2 isolates
por: Bojkova, Denisa, et al.
Publicado: (2022)

Identification of Z-Tyr-Ala-CHN(2), a Cathepsin L Inhibitor with Broad-Spectrum Cell-Specific Activity against Coronaviruses, including SARS-CoV-2
por: Doijen, Jordi, et al.
Publicado: (2023)

Human Mesenchymal Stromal Cells Are Resistant to SARS-CoV-2 Infection under Steady-State, Inflammatory Conditions and in the Presence of SARS-CoV-2-Infected Cells
por: Schäfer, Richard, et al.
Publicado: (2020)

Optimized qRT-PCR Approach for the Detection of Intra- and Extra-Cellular SARS-CoV-2 RNAs
por: Toptan, Tuna, et al.
Publicado: (2020)

Targeting the Pentose Phosphate Pathway for SARS-CoV-2 Therapy
por: Bojkova, Denisa, et al.
Publicado: (2021)

SARS-CoV-2 Variants Show Different Host Cell Proteome Profiles With Delayed Immune Response Activation in Omicron-Infected Cells
por: Metzler, Melinda, et al.
Publicado: (2023)

A SARS-CoV-2 cytopathicity dataset generated by high-content screening of a large drug repurposing collection
por: Ellinger, Bernhard, et al.
Publicado: (2021)

Differentially conserved amino acid positions may reflect differences in SARS-CoV-2 and SARS-CoV behaviour
por: Bojkova, Denisa, et al.
Publicado: (2021)

Characterization of ACE Inhibitors and AT(1)R Antagonists with Regard to Their Effect on ACE2 Expression and Infection with SARS-CoV-2 Using a Caco-2 Cell Model
por: Reus, Philipp, et al.
Publicado: (2021)

COVID-19-Related Coagulopathy—Is Transferrin a Missing Link?
por: McLaughlin, Katie-May, et al.
Publicado: (2020)

Silver N-heterocyclic carbene complexes are potent uncompetitive inhibitors of the papain-like protease with antiviral activity against SARS-CoV-2
por: Gil-Moles, Maria, et al.
Publicado: (2023)

Aprotinin Inhibits SARS-CoV-2 Replication
por: Bojkova, Denisa, et al.
Publicado: (2020)

Functional annotation of human cytomegalovirus gene products: an update
por: Van Damme, Ellen, et al.
Publicado: (2014)

Ibuprofen, Flurbiprofen, Etoricoxib or Paracetamol Do Not Influence ACE2 Expression and Activity In Vitro or in Mice and Do Not Exacerbate In-Vitro SARS-CoV-2 Infection
por: de Bruin, Natasja, et al.
Publicado: (2022)

Identification of novel antiviral drug candidates using an optimized SARS-CoV-2 phenotypic screening platform
por: Bojkova, Denisa, et al.
Publicado: (2023)

Famotidine inhibits toll-like receptor 3-mediated inflammatory signaling in SARS-CoV-2 infection
por: Mukherjee, Rukmini, et al.
Publicado: (2021)

Evidence of SARS-CoV-2 Infection in Returning Travelers from Wuhan, China
por: Hoehl, Sebastian, et al.
Publicado: (2020)

Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants
por: Wagner, Julian U. G., et al.
Publicado: (2021)

Detection and infectivity of SARS-CoV-2 in exhumated corpses
por: Plenzig, S., et al.
Publicado: (2021)

Discovery of anti-SARS-CoV-2 secondary metabolites from the heartwood of Pterocarpus santalinus using multi-informative molecular networking
por: Wasilewicz, Andreas, et al.
Publicado: (2023)

SARS-CoV-2 screening strategies for returning international travellers: Evaluation of a rapid antigen test approach
por: Layer, Emily, et al.
Publicado: (2022)

Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity
por: Shin, Donghyuk, et al.
Publicado: (2020)

A Potential Role of the CD47/SIRPalpha Axis in COVID-19 Pathogenesis
por: McLaughlin, Katie-May, et al.
Publicado: (2021)

Omeprazole Increases the Efficacy of Acyclovir Against Herpes Simplex Virus Type 1 and 2
por: Michaelis, Martin, et al.
Publicado: (2019)

USP22 controls type III interferon signaling and SARS-CoV-2 infection through activation of STING
por: Karlowitz, Rebekka, et al.
Publicado: (2022)

HCMV Displays a Unique Transcriptome of Immunomodulatory Genes in Primary Monocyte-Derived Cell Types
por: Van Damme, Ellen, et al.
Publicado: (2016)

Enisamium Inhibits SARS-CoV-2 RNA Synthesis
por: Elli, Stefano, et al.
Publicado: (2021)

Antiviral Activity and Safety of Darunavir/Cobicistat for the Treatment of COVID-19
por: Chen, Jun, et al.
Publicado: (2020)

Reply to: “Antiviral Activity and Safety of Darunavir/Cobicistat for Treatment of COVID-19”
por: Nicolini, Laura Ambra, et al.
Publicado: (2020)

Predicted antiviral drugs Darunavir, Amprenavir, Rimantadine and Saquinavir can potentially bind to neutralize SARS-CoV-2 conserved proteins
por: Halder, Umesh C.
Publicado: (2021)

Identification of Natural Products Inhibiting SARS-CoV-2 by Targeting Viral Proteases: A Combined in Silico and in Vitro Approach
por: Wasilewicz, Andreas, et al.
Publicado: (2023)

Ceftriaxone/cobicistat/darunavir/hydroxychloroquine: Off-label use and lack of efficacy: case report
Publicado: (2022)

Glucocorticosteroids trigger reactivation of human cytomegalovirus from latently infected myeloid cells and increase the risk for HCMV infection in D+R+ liver transplant patients
por: Van Damme, Ellen, et al.
Publicado: (2015)

Development of antiviral therapy for severe acute respiratory syndrome
por: Cinatl, Jindrich, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_32pajrudv5nk3vhslncg2urcpg